Skip to content
IPOandMore
  • Home
  • IPO/OFS/Stocks
    • IPO Review
    • Post IPO Analysis
    • Stock Analysis
  • Buybacks / Spl Situations
    • Recent Buybacks (Last 50)
    • All BuyBacks
    • Buyback Review
    • Special Situations
  • NCDs / Fixed Income
    • Fixed Income
    • NCD ReviewNCD Analysis & Review
  • Mutual Funds
  • Personal Finance
  • NRI
  • About
  • Toggle website search
Menu Close
  • Home
  • IPO/OFS/Stocks
    • IPO Review
    • Post IPO Analysis
    • Stock Analysis
  • Buybacks / Spl Situations
    • Recent Buybacks (Last 50)
    • All BuyBacks
    • Buyback Review
    • Special Situations
  • NCDs / Fixed Income
    • Fixed Income
    • NCD Review
  • Mutual Funds
  • Personal Finance
  • NRI
  • About
  • Toggle website search

IPO Analysis

  1. Home>
  2. IPO Analysis>
  3. Page 2

CDSL IPO: Brokerage Views & Runup to IPO

  • Post author:[email protected]
  • Post published:June 17, 2017
  • Post category:IPO Review
  • Post comments:0 Comments

This post on CDSL IPO tries to bring out consolidated brokerage views opinions, IPO Review / Analysis, Note/ reports and recommendation of brokerages , Analyst, Business New papers, Management views, information…

Continue ReadingCDSL IPO: Brokerage Views & Runup to IPO

CDSL IPO Analysis: No room for Second Thought

  • Post author:[email protected]
  • Post published:June 17, 2017
  • Post category:IPO Review
  • Post comments:0 Comments

Central Depository Services (India) Limited (CDSL), a leading securities depository in the country is coming out with Public issue of 35,167,208 Equity Shares by way of an Offer for Sale.…

Continue ReadingCDSL IPO Analysis: No room for Second Thought

Eris LifeSciences IPO Analysis

  • Post author:[email protected]
  • Post published:June 14, 2017
  • Post category:IPO Review/Uncategorized
  • Post comments:0 Comments

Eris Lifesciences IPO which opens on Friday 16th June 2017, comprises  an offer for sale (OFS) by PE firm ChrysCapital  promoters and other shareholders. The issue will be raising Rs.…

Continue ReadingEris LifeSciences IPO Analysis
  • Go to the previous page
  • 1
  • 2

Archives

Categories

Copyright - WordPress Theme by OceanWP